Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $89 | $60 | $128 | $59 |
| Short-Term Investments | $231 | $216 | $206 | $236 |
| Receivables | $19 | $15 | $6 | $1 |
| Inventory | $19 | $9 | $3 | $0 |
| Other Curr. Assets | $16 | $9 | $12 | $12 |
| Total Curr. Assets | $374 | $308 | $354 | $308 |
| Property Plant & Equip (Net) | $4 | $2 | $3 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $7 | $8 | $5 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $15 | $17 | $12 |
| Total NC Assets | $18 | $24 | $28 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $392 | $333 | $382 | $330 |
| Liabilities | – | – | – | – |
| Payables | $12 | $5 | $5 | $6 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $1 | $7 |
| Other Curr. Liab. | $102 | $48 | $33 | $30 |
| Total Curr. Liab. | $116 | $55 | $40 | $43 |
| LT Debt | $4 | $0 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $108 | $107 | $77 | $0 |
| Total NC Liab. | $112 | $108 | $78 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $1 | $2 | $3 |
| Total Liabilities | $228 | $163 | $118 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $143 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,155 | -$895 | -$710 | -$529 |
| AOCI | -$0 | $0 | -$0 | -$0 |
| Other Equity | $1,177 | $1,064 | $974 | $813 |
| Total Equity | $165 | $170 | $264 | $284 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $392 | $333 | $382 | $330 |
| Net Debt | -$85 | -$59 | -$126 | -$57 |